Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-24 @ 6:55 PM
NCT ID:
NCT05667857
Eligibility Criteria:
Inclusion Criteria:
1. Non-intervention group:
* Provision of written informed consent
* Diagnosed with advanced cancer of any type
* Initiated immunotherapy (Anti-PD1, Anti-PDL1, CTLA-4, …) at least one year ago
* Have a confirmed normalization on whole-body 18F-FDG PET
* English, Dutch or French-speaking
2. Integrative neurocognitive remediation therapy group:
* Provision of written informed consent
* Objective cognitive impairment and/or subjective cognitive complaints
* Confirmed normalization on whole-body 18F-FDG PET for patients (cohort 1)
* Disease-free (cohort 2) or no active disease for patients with CNS tumors (cohort 3)
* Having received a cancer therapy of any kind
* Having ended cancer treatment (immunotherapy, chemotherapy, radiotherapy, surgery, …) with an exception of ongoing adjuvant hormone therapy
* Dutch or French speaking
Exclusion Criteria:
* severe co-morbid non cancer-related psychiatric disorders such as psychosis, obsessive compulsive disorders, eating disorders etc., patients with cognitive impairment related to dementia, and patients that are physically or mentally not able to fill in the questionnaires
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05667857
Study Brief:
Protocol Section:
NCT05667857